KR101748712B1 - 호흡기 질환의 치료 또는 예방 방법 - Google Patents

호흡기 질환의 치료 또는 예방 방법 Download PDF

Info

Publication number
KR101748712B1
KR101748712B1 KR1020157017530A KR20157017530A KR101748712B1 KR 101748712 B1 KR101748712 B1 KR 101748712B1 KR 1020157017530 A KR1020157017530 A KR 1020157017530A KR 20157017530 A KR20157017530 A KR 20157017530A KR 101748712 B1 KR101748712 B1 KR 101748712B1
Authority
KR
South Korea
Prior art keywords
cells
stro
cell
asthma
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157017530A
Other languages
English (en)
Korean (ko)
Other versions
KR20150090237A (ko
Inventor
실비우 이테스쿠
라비 크리쉬난
피터 고쉬
Original Assignee
메소블라스트, 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메소블라스트, 아이엔씨. filed Critical 메소블라스트, 아이엔씨.
Publication of KR20150090237A publication Critical patent/KR20150090237A/ko
Application granted granted Critical
Publication of KR101748712B1 publication Critical patent/KR101748712B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020157017530A 2012-12-12 2013-12-12 호흡기 질환의 치료 또는 예방 방법 Active KR101748712B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
US61/736,352 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Publications (2)

Publication Number Publication Date
KR20150090237A KR20150090237A (ko) 2015-08-05
KR101748712B1 true KR101748712B1 (ko) 2017-06-19

Family

ID=50933587

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157017530A Active KR101748712B1 (ko) 2012-12-12 2013-12-12 호흡기 질환의 치료 또는 예방 방법

Country Status (11)

Country Link
US (3) US10028979B2 (enExample)
EP (1) EP2931373B1 (enExample)
JP (5) JP6313327B2 (enExample)
KR (1) KR101748712B1 (enExample)
CN (2) CN115919901A (enExample)
AU (4) AU2013360026B2 (enExample)
CA (1) CA2893951C (enExample)
ES (1) ES2759281T3 (enExample)
IL (1) IL239309A0 (enExample)
SG (2) SG10201807682PA (enExample)
WO (1) WO2014089625A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2931373B1 (en) 2012-12-12 2019-08-21 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
WO2016049156A1 (en) * 2014-09-23 2016-03-31 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
BR112020004856A2 (pt) * 2017-09-15 2020-09-15 Cynata Therapeutics Limited método para tratar doença alérgica das vias aéreas (aad)/asma
US20230086254A1 (en) * 2020-01-30 2023-03-23 Jcr Pharmaceuticals Co., Ltd. Medicinal composition comprising dental pulp-derived cells
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
DE60314602T2 (de) * 2002-02-19 2008-02-28 Medipost, Co., Ltd. Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US20080260694A1 (en) * 2004-09-24 2008-10-23 Angioblast Systems, Inc. Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof
KR101617319B1 (ko) * 2005-04-12 2016-05-02 메소블라스트, 아이엔씨. 조직 비특이적인 알카리 포스파타제에 의한 다분화성 성체 세포의 분리
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
ES2923016T3 (es) * 2007-08-06 2022-09-22 Mesoblast Inc Células precursoras mesenquimales TNAP+ para el tratamiento de enfermedades del tejido conectivo
JP5539886B2 (ja) * 2007-10-17 2014-07-02 ティクセル Ｔｒ１細胞、間葉系幹細胞およびその使用
CN102144028B (zh) * 2008-09-03 2017-12-26 中胚有限公司 造血前体的扩增
KR101871472B1 (ko) * 2010-07-02 2018-06-27 메소블라스트, 아이엔씨. 이식편대숙주 질환의 치료 방법
CN109432126B (zh) * 2011-03-11 2022-06-14 儿童医学中心公司 与间充质干细胞外来体相关的方法和组合物
CN109276706A (zh) * 2011-06-03 2019-01-29 麦瑟布莱斯特公司 治疗或预防神经性疾病的方法
EP2931373B1 (en) 2012-12-12 2019-08-21 Mesoblast, Inc. Methods of treating or preventing respiratory conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Tracey L. Bonfield, et al. Am J Physiol Lung Cell Mol Physiol. Vol.299(6): p.760-770. (2010.09.03. 공개)*

Also Published As

Publication number Publication date
JP2024041904A (ja) 2024-03-27
US10028979B2 (en) 2018-07-24
CA2893951A1 (en) 2014-06-19
US20200289578A1 (en) 2020-09-17
AU2020202022A1 (en) 2020-04-09
JP2020097618A (ja) 2020-06-25
CA2893951C (en) 2022-05-03
JP6665218B2 (ja) 2020-03-13
AU2022209219B2 (en) 2025-08-14
SG10201807682PA (en) 2018-10-30
US20190046575A1 (en) 2019-02-14
US10688134B2 (en) 2020-06-23
JP2022065132A (ja) 2022-04-26
IL239309A0 (en) 2015-07-30
AU2022209219A1 (en) 2022-08-18
US20150306146A1 (en) 2015-10-29
WO2014089625A1 (en) 2014-06-19
JP2018118987A (ja) 2018-08-02
EP2931373A1 (en) 2015-10-21
EP2931373A4 (en) 2016-05-04
JP2016502980A (ja) 2016-02-01
CN115919901A (zh) 2023-04-07
AU2018226514A1 (en) 2018-09-27
AU2013360026B2 (en) 2018-06-21
AU2013360026A1 (en) 2015-07-02
CN105377274A (zh) 2016-03-02
ES2759281T3 (es) 2020-05-08
SG11201504352TA (en) 2015-07-30
AU2018226514B2 (en) 2020-01-02
HK1210077A1 (en) 2016-04-15
JP7420844B2 (ja) 2024-01-23
EP2931373B1 (en) 2019-08-21
JP6313327B2 (ja) 2018-04-18
KR20150090237A (ko) 2015-08-05

Similar Documents

Publication Publication Date Title
JP7420844B2 (ja) 呼吸器系疾患を治療又は予防する方法
JP2023030116A (ja) 内皮機能不全及び炎症の疾患の治療
CN103841983A (zh) 治疗或预防神经性疾病的方法
AU2016247132B2 (en) Methods for treating obesity and/or metabolic syndrome
US20240024366A1 (en) Methods of treating or preventing respiratory conditions
HK1210077B (en) Methods of treating or preventing respiratory conditions
HK1210209B (en) Treatment of diseases of endothelial dysfunction and inflammation
HK40014520A (en) Treatment of diseases of endothelial dysfunction and inflammation
HK1195488A (en) Methods for treating obesity and/or metabolic syndrome
HK1195488B (en) Methods for treating obesity and/or metabolic syndrome

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20150630

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160504

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20170329

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20170613

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20170614

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20210517

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20230427

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20240514

Start annual number: 8

End annual number: 8